<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.3390/diagnostics14050492</dc:identifier><dc:language>eng</dc:language><dc:creator>Arias-Alvarez, Marta</dc:creator><dc:creator>Sopeña-Pinilla, Maria</dc:creator><dc:creator>Fernandez-Espinosa, Guisela</dc:creator><dc:creator>Orduna-Hospital, Elvira</dc:creator><dc:creator>Vicente-Garza, Ines</dc:creator><dc:creator>Bonet-Rodriguez, Anna</dc:creator><dc:creator>Acha-Perez, Javier</dc:creator><dc:creator>Rodriguez-Mena, Diego</dc:creator><dc:creator>Pinilla, Isabel</dc:creator><dc:title>Retinal Function in Long-Term Type 1 Diabetes without Retinopathy: Insights from Pattern Electroretinogram and Pattern Visual Evoked Potentials Assessments</dc:title><dc:identifier>ART-2024-137410</dc:identifier><dc:description>Background: To evaluate changes in pattern electroretinogram (pERG) and pattern visual evoked potentials (pVEP) in patients with long-lasting type 1 diabetes without diabetic retinopathy (DR). Methods: Prospective study involving 92 eyes divided into two groups. The diabetic group included 46 eyes of 23 patients with type 1 diabetes (T1DM); the control group included 23 age-matched healthy subjects. pERG and pVEP were assessed using the RETI-port/scan21 recording software (version 1021.3.0.0). Results: Mean age was 48 ± 9.77 years for the diabetic group and 51.7 ± 4.75 years for the control group. The mean duration of diabetes was 28.88 ± 8.04 years. The mean HbA1c value was 7.29 ± 0.89%. There were no differences in the age or sex distribution. Regarding the pERG, T1DM patients exhibited a significant decrease in the amplitude of the P50 and N95 waves compared to the control group (p = 0.018 and p = 0.035, respectively), with no differences in the peak time of each component. pVEP showed no significant changes in either peak time or amplitude of the different components. Conclusions: Long-term T1DM patients without DR showed changes in the amplitude of pERG waves with preserved peak times. We did not observe modifications in pVEP. pERG may serve as a subclinical marker of ganglion cell damage in long-term T1DM patients.</dc:description><dc:date>2024</dc:date><dc:source>http://zaguan.unizar.es/record/132165</dc:source><dc:doi>10.3390/diagnostics14050492</dc:doi><dc:identifier>http://zaguan.unizar.es/record/132165</dc:identifier><dc:identifier>oai:zaguan.unizar.es:132165</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/ISCIII-FEDER/PI20-00740</dc:relation><dc:identifier.citation>Diagnostics 14, 5 (2024), 492 [11 pp.]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>https://creativecommons.org/licenses/by/4.0/deed.es</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>